John O DaSilva (John DaSilva)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Diffusion Weighted

Tyrosine Kinase

Papillary Thyroid

Top Venues

Molecular cancer therapeutics

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Andres E Perez Bay, Devon Faulkner, John O DaSilva, Tara M Young, Katie Yang, Jason T Giurleo, Dangshe Ma, Frank J Delfino, William C Olson, Gavin Thurston, Christopher Daly, Julian Andreev
A Bispecific METxMET Antibody-Drug Conjugate with Cleavable Linker Is Processed in Recycling and Late Endosomes. Molecular cancer therapeutics 22 (3) (2023)
Andres E Perez Bay, Devon Faulkner, John O DaSilva, Tara M Young, Katie Yang, Jason T Giurleo, Dangshe Ma, Frank J Delfino, William C Olson, Gavin Thurston, Christopher Daly, Julian Andreev
A Bispecific METxMET Antibody-Drug Conjugate with Cleavable Linker Is Processed in Recycling and Late Endosomes. Molecular cancer therapeutics 22 (3) (2023)
Andres E Perez Bay, Devon Faulkner, John O DaSilva, Tara M Young, Katie Yang, Jason T Giurleo, Dangshe Ma, Frank J Delfino, William C Olson, Gavin Thurston, Christopher Daly, Julian Andreev
A Bispecific METxMET Antibody-Drug Conjugate with Cleavable Linker Is Processed in Recycling and Late Endosomes. Molecular cancer therapeutics 22 (3) (2023)
Seung Yeon Oh, You Won Lee, Eun Ji Lee, Seok-Young Kim, Young Joon Park, Seong Gu Heo, Mi Ra Yu, Min Hee Hong, John O DaSilva, Christopher Daly, Byoung Chul Cho, Sun Min Lim, Mi Ran Yun
Preclinical study of a biparatopic METxMET Antibody-Drug Conjugate, REGN5093-M114, overcomes MET-driven acquired resistance to EGFR TKIs in EGFR-mutant NSCLC. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)